by Richard Daverman, PhD
December 12, 2013 -- Sihuan Pharma signed a cooperation agreement with Dutch pharmaceutical company to-BBB to develop innovative CNS drugs. Sihuan will gain access to to-BBB’s G-Technology®, a patented delivery system that allows drugs to cross the blood-brain barrier and, at the same time, facilitates sustained release of the active ingredients. Initially, the two companies will perform feasibility studies on certain of Sihuan’s existing drugs. If successful, the tests will lead to a collaborative effort to develop one or more compounds. More details....
Help employers find you! Check out all the jobs and post your resume.
